WASHINGTON Copaxone, a blockbuster drug manufactured by Israel’s Teva Industries, has proven to be ineffective for the treatment of amyotrophic lateral sclerosis, according to the company. Copaxone, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback